17

Grape King Bio Ltd

1707 · TW · Healthcare / Drug Manufacturers - Specialty & Generic

79.50TWD+0.70 (+0.89%)

Price History

Full chart

Market Stats

Previous Close78.80
Open78.80
Day Range78.70 – 79.70
52-Week Range85.10 – 130.00
Volume153.25K
Market Cap12.67B
P/E (TTM)11.10
Forward P/E17.36
EPS7.70
Dividend Yield7.00%
Beta0.23
50-Day Avg89.28
200-Day Avg107.37

About

Grape King Bio Ltd, together with its subsidiaries, produces and sells pharmaceutical preparations, patent medicines, liquid tonics, drinks, and healthy food in Taiwan, China, and internationally. It operates through Multi-Level Marketing; Distributors; Original Design Manufacturer/Original Equipment Manufacturer; and Sales Channel segments. The company provides health products and supplements; and microbial fermentation for mushroom mycelium, probiotics, and enzymes. It also offers functional ingredients for intestinal care, immunity regulation, liver care, brain health, eye care, weight control, feminine health, sensual health care, and others. It serves pharmaceutical preparations, finished drugs, oral liquids, and beverages and health foods. The company was founded in 1969 and is headquartered in Taoyuan City, Taiwan.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Sheng-Lin Tseng Ph.D.
  • Employees0
  • HeadquartersNo. 402, Jinling Road, Taoyuan City, Taiwan, 324, Taiwan
  • Websitehttps://www.grapeking.com.tw

Leadership

  • Mr. Sheng-Lin Tseng Ph.D.Chairman & GM
  • Mr. Nick HungAccounting Supervisor, CFO & Corporate Governance Officer
  • Mr. Du-Sheng WangDirector of Administration Division
  • Mr. Bing-Jyun CueiChief Legal Officer
  • Chung-Chi HungChief Internal Auditor

Financials

Income Statement

Currency: TWD2002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue1.06B1.20B1.25B1.30B1.49B1.70B2.11B2.82B3.28B3.77B4.61B5.65B6.28B7.25B9.19B9.39B9.18B9.24B9.17B9.80B10.39B10.64B11.16B10.25B
Growth (%)-+13.46%+4.10%+4.28%+14.29%+14.26%+24.11%+33.58%+16.32%+14.89%+22.29%+22.57%+11.15%+15.36%+26.73%+2.21%-2.18%+0.61%-0.77%+6.87%+6.05%+2.35%+4.93%-8.14%
Cost of Revenue667.89M721.88M773.23M785.24M915.38M1.03B1.30B477.51M521.05M513.95M583.53M657.39M721.62M862.71M1.27B1.52B1.85B1.67B1.63B1.94B1.91B2.10B2.50B2.55B
Gross Profit----574.30M672.96M810.36M2.34B2.76B3.26B4.03B5.00B5.56B6.39B7.92B7.86B7.33B7.57B7.54B7.86B8.48B8.54B8.66B7.70B
Gross Margin----38.55%39.54%38.36%83.08%84.13%86.37%87.35%88.37%88.51%88.10%86.22%83.77%79.81%81.89%82.21%80.18%81.63%80.26%77.58%75.08%
Operating Expense----332.82M361.44M456.83M1.81B2.11B2.49B3.06B3.65B3.96B4.57B5.69B5.61B4.98B5.11B5.14B5.44B5.79B6.04B6.16B5.56B
Operating Income94.71M71.81M157.50M200.45M241.48M311.52M353.53M536.54M654.03M770.55M966.37M1.34B1.60B1.81B2.23B2.25B2.35B2.46B2.39B2.42B2.69B2.50B2.50B2.14B
Operating Margin8.95%5.98%12.60%15.38%16.21%18.30%16.74%19.01%19.93%20.43%20.95%23.74%25.46%25.01%24.32%24.01%25.59%26.60%26.10%24.69%25.90%23.47%22.40%20.89%
EBITDA----346.92M434.21M404.99M677.37M785.39M917.13M1.13B1.55B1.82B2.06B2.55B2.65B2.70B2.77B2.80B2.85B3.14B3.12B3.16B2.69B
EBITDA Margin----23.29%25.51%19.17%24.00%23.93%24.32%24.54%27.42%28.91%28.37%27.80%28.20%29.37%29.96%30.51%29.06%30.23%29.36%28.31%26.23%
Net Income42.42M28.49M81.34M-150.42M180.87M164.52M379.34M427.70M473.06M618.90M835.76M942.48M1.05B1.30B1.35B1.30B1.94B1.90B1.95B2.17B1.45B1.45B1.22B
Net Income Margin4.01%2.37%6.51%-10.10%10.63%7.79%13.44%13.03%12.54%13.42%14.79%15.00%14.51%14.12%14.40%14.11%20.98%20.67%19.88%20.88%13.66%12.98%11.88%
R&D35.48M30.98M33.41M39.97M40.49M45.30M52.15M60.87M66.91M85.21M77.65M91.97M84.26M98.68M114.03M159.66M184.57M190.09M252.86M292.23M289.88M289.55M291.91M273.39M
R&D as % of Total Revenue3.35%2.58%2.67%3.07%2.72%2.66%2.47%2.16%2.04%2.26%1.68%1.63%1.34%1.36%1.24%1.70%2.01%2.06%2.76%2.98%2.79%2.72%2.62%2.67%
Interest Expense000015.18M13.36M9.11M4.17M5.85M1.53M1.84M132.00K86.00K23.14M31.71M17.58M13.86M17.69M14.34M4.01M2.37M2.54M3.04M4.68M
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%1.02%0.78%0.43%0.15%0.18%0.04%0.04%0.00%0.00%0.32%0.35%0.19%0.15%0.19%0.16%0.04%0.02%0.02%0.03%0.05%

Balance Sheet

Currency: TWD2002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets2.48B2.31B2.45B2.37B2.48B2.53B2.59B3.21B3.20B3.46B3.87B4.63B5.37B8.61B9.55B9.89B10.65B11.36B13.10B14.06B15.05B15.51B15.32B15.74B
Total Liabilities1.02B826.42M875.75M768.01M785.85M753.00M841.61M1.13B941.33M984.40M1.13B1.41B1.65B4.39B3.77B3.56B3.71B3.89B5.13B3.63B3.91B3.88B3.53B3.67B
Total Equity1.46B1.48B1.58B1.60B1.66B1.72B1.68B1.94B2.08B2.22B2.43B2.77B3.07B3.48B4.81B5.20B5.73B6.17B6.62B8.99B9.57B9.98B10.06B10.34B
Cash60.13M118.38M125.55M88.41M419.49M311.30M364.17M676.64M595.01M853.43M1.08B1.07B1.37B1.43B1.90B1.92B2.05B2.15B2.93B3.64B4.67B4.82B4.34B4.16B
Total Debt----314.90M205.91M219.92M233.11M63.70M68.80M16.21M13.40M6.39M2.51B1.39B1.03B1.12B1.34B2.08B271.76M157.75M192.92M160.91M215.03M
Net Debt-----104.59M-105.39M-144.25M-443.54M-531.31M-784.63M-1.07B-1.06B-1.37B1.08B-507.71M-891.44M-929.66M-803.21M-843.04M-3.36B-4.52B-4.63B-4.18B-3.95B

Cash Flow

Currency: TWD2002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow76.42M136.42M49.53M350.26M468.84M253.11M434.85M720.61M683.89M848.53M1.12B1.58B1.70B1.31B2.80B2.50B2.42B2.17B2.72B2.54B2.99B2.52B1.88B2.18B
Investing Cash Flow49.12M138.31M---25.14M-74.00M-133.57M-228.32M-232.30M-145.88M-270.39M-887.21M-498.54M-2.65B-808.74M-908.30M-1.13B-689.51M-1.23B-462.34M-330.31M-654.73M-662.11M-580.08M
Financing Cash Flow-----110.29M-286.77M-247.07M-185.92M-518.68M-442.37M-612.19M-688.96M-898.20M1.40B-1.53B-1.56B-1.15B-1.37B-722.80M-1.37B-1.63B-1.71B-1.72B-1.77B
Capital Expenditure19.39M24.45M51.69M130.55M56.68M113.03M125.96M190.47M732.58M143.59M159.25M354.58M198.33M2.64B753.84M774.78M1.12B655.32M1.23B278.40M502.47M601.39M647.89M445.51M
Free Cash Flow----412.16M140.08M308.89M530.14M-48.69M704.93M962.01M1.22B1.50B-1.33B2.05B1.72B1.30B1.52B1.49B2.26B2.49B1.92B1.23B1.73B
Dividends Paid---52.33M112.28M150.41M211.72M192.63M350.19M448.12M557.77M686.05M898.32M1.09B1.09B1.29B1.43B882.56M884.21M948.08M903.64M1.02B1.02B1.02B
FCF to OCF----87.91%55.34%71.03%73.57%-7.12%83.08%85.80%77.50%88.34%-101.79%73.11%68.96%53.61%69.82%54.91%89.05%83.20%76.13%65.46%79.56%
Dividend Paid to FCF----27.24%107.38%68.54%36.33%-719.24%63.57%57.98%56.18%59.76%-81.92%53.00%74.79%110.16%58.21%59.22%41.88%36.32%53.29%83.24%58.94%

Earnings

Report DateOct 29, 2008Mar 31, 2009Jun 30, 2009Oct 29, 2009Dec 31, 2009Apr 25, 2011Aug 31, 2011Oct 28, 2011Mar 30, 2012May 30, 2012Aug 29, 2012Oct 31, 2012Mar 28, 2013May 29, 2013Aug 14, 2013Nov 14, 2013Feb 26, 2014May 9, 2014Aug 14, 2014Nov 14, 2014Mar 31, 2015Apr 1, 2015Aug 12, 2015Nov 11, 2015Mar 17, 2016May 13, 2016Aug 12, 2016Nov 11, 2016Mar 22, 2017May 11, 2017Aug 11, 2017Nov 9, 2017Feb 23, 2018May 11, 2018Aug 9, 2018Nov 14, 2018Feb 25, 2019May 14, 2019Aug 1, 2019Nov 11, 2019Feb 25, 2020May 6, 2020Aug 5, 2020Nov 4, 2020Feb 25, 2021May 5, 2021Aug 3, 2021Nov 4, 2021Feb 24, 2022May 12, 2022Aug 11, 2022Nov 8, 2022Feb 22, 2023May 10, 2023Aug 10, 2023Nov 10, 2023Feb 26, 2024May 14, 2024Aug 13, 2024Nov 11, 2024May 12, 2025Aug 11, 2025Nov 13, 2025Mar 31, 2026Aug 14, 2026
EPS Estimate0.51--0.55-0.74-1.010.98--1.021.14-1.561.25-1.691.821.812.112.111.891.592.432.212.482.572.952.432.222.882.901.962.332.593.042.042.472.693.151.962.632.072.931.782.262.223.081.852.132.163.171.812.462.353.361.942.382.431.902.282.121.361.37
EPS Actual0.320.290.740.741.150.751.040.521.041.171.051.241.301.331.541.581.961.491.621.892.222.221.871.982.282.112.192.462.811.902.372.433.251.922.132.492.971.932.312.233.141.922.092.223.061.602.202.032.951.582.592.453.191.882.282.473.161.732.212.801.401.821.99-1.56
Surprise-37.25%--34.55%-1.35%--48.51%6.12%--21.57%14.04%--1.28%26.40%--11.83%-10.99%4.42%5.21%5.21%-1.06%24.53%-6.17%-4.52%-11.69%-4.28%-4.75%-21.81%6.76%-15.63%12.07%-2.04%-8.58%-3.86%-2.30%-5.39%-6.48%-17.10%-0.32%-2.04%-20.53%7.25%4.44%-10.11%-2.65%-8.56%-4.22%-14.59%21.60%13.43%0.63%3.87%-7.32%5.11%-5.95%-10.82%-7.14%15.23%-26.32%-20.18%-6.13%-13.87%
TimingAfter-hours--After-hours-After-hours-After-hoursAfter-hours--After-hoursAfter-hours-Pre-marketPre-market-Pre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-Pre-market

Key Statistics & Ratios

Market Cap12.67B
Enterprise Value9.39B
Trailing P/E11.10
Forward P/E17.36
PEG Ratio0.00
Price / Sales1.25
Price / Book1.26
EPS7.70
Book Value69.11
Revenue (TTM)10.12B
Gross Profit (TTM)7.44B
EBITDA2.50B
Profit Margin11.34%
Operating Margin17.12%
Return on Equity15.59%
Return on Assets8.51%
Shares Outstanding148.14M
Shares Float115.73M
Beta0.23
Dividend Yield7.00%
Dividend Rate6.00
Payout Ratio77.98%

Dividends

20231×
6.90Jun 20, 2023
20221×
6.10Jun 15, 2022
20211×
6.40Aug 2, 2021
20201×
6.50Jun 24, 2020
20191×
6.50Jun 24, 2019
20181×
6.68Jul 9, 2018
20171×
6.40Jul 11, 2017
20161×
5.60Jul 18, 2016
20151×
5.30Jul 27, 2015
20141×
5.00Jul 9, 2014
20131×
3.70Jul 3, 2013
20121×
3.00Jul 11, 2012
20111×
2.50Jul 8, 2011
20101×
2.00Jul 1, 2010
20091×
1.00Jul 7, 2009
20081×
1.20Jul 4, 2008
20071×
0.80Jul 9, 2007
20061×
0.60Aug 3, 2006
20051×
0.41Sep 15, 2005

Stock Splits

  • Sep 15, 20052041:2000
  • Dec 2, 1998611:593
  • Oct 1, 199853:50
  • Oct 23, 199711:10
  • Nov 25, 199411:10